Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study ...

An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be beneficial for select candidates, though a pivotal study did not meet its ...

My husband had left knee replacement surgery three weeks ago. He has had continuous unrelenting pain since. He was initially ...

Poor hearing increases a person’s risk of developing heart failure, according to a study (Alamy/PA) Poor hearing increases a person’s risk of developing heart failure, according to a study.

New Abbott Heart Failure leaders Dr. Finn Gustafsson and Katie Spayde. [Images from LinkedIn] A leader in the Abbott (NYSE: ABT) + Heart Failure division announced on social media that the company ...

CoDE-HF (Collaboration for the Diagnosis and Evaluation of Heart Failure) uses an eXtreme Gradient Boosting ... testing will become increasingly important. In people with preserved ejection fraction, ...

Switching to tirzepatide linked to additional reduction in HbA1c, weight loss compared with escalating dulaglutide. HealthDay News — For patients with inadequately controlled type 2 diabetes ...

Participants given tirzepatide lowered their HbA1c by a mean 0.77% more than those given a higher dulaglutide dose. More tirzepatide participants hit a weight loss threshold known for disease ...

“I believe that the challenge this country faces today from the United States, as real and serious as it is, should not be another excuse for Liberal failure,” he said. The Conservatives said ...

yet studies suggest only about one in 10 patients with heart failure ever transition to hospice services.” To more effectively address the needs of this underserved demographic, VITAS recently became ...

Tirzepatide reduced cardiovascular events ... new data aim to help clinicians better approach complex cases of heart failure (HF), especially among patients with overlapping comorbidities.